Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant

od Liu, Qiuying, Harris, Nicholas, Epperla, Narendranath, Andritsos, Leslie A
izdano v Onco Targets Ther (2021)

Hearing Loss due to Infiltration of the Tympanic Membrane by Chronic Lymphocytic Leukemia

od Cohen, Jonathon B., Cavaliere, Robert, Byrd, John C., Andritsos, Leslie A.
Izdano 2012

Ruxolitinib In The Treatment Of Polycythemia Vera: An Update On Health-Related Quality Of Life And Patient-Reported Outcomes

od Cingam, Shashank, Flatow-Trujillo, Lainey, Andritsos, Leslie A, Arana Yi, Cecilia
izdano v J Blood Med (2019)

Co-Treatment of Hairy Cell Leukemia and Melanoma with the BRAF Inhibitor Dabrafenib

od Blachly, James S., Lozanski, Gerard, Lucas, David M., Grever, Michael R., Kendra, Kari, Andritsos, Leslie A.
izdano v J Natl Compr Canc Netw (2015)

Predictive performance of early warning scores in acute leukemia patients receiving induction chemotherapy

od Vaughn, John L., Kline, David, Denlinger, Nathan M., Andritsos, Leslie A., Exline, Matthew C., Walker, Alison R.
izdano v Leuk Lymphoma (2017)

RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans

od Troeger, Anja, Johnson, Amy J., Wood, Jenna, Blum, William G., Andritsos, Leslie A., Byrd, John C., Williams, David A.
Izdano 2012

A phase 1 clinical trial of flavopiridol consolidation in chronic lymphocytic leukemia patients following chemoimmunotherapy

od Awan, Farrukh T., Jones, Jeffrey A., Maddocks, Kami, Poi, Ming, Grever, Michael R., Johnson, Amy, Byrd, John C., Andritsos, Leslie A.
izdano v Ann Hematol (2016)

Classic hairy cell leukemia complicated by pancytopenia and severe infection: a report of 3 cases treated with vemurafenib

od Shenoi, Daniel P., Andritsos, Leslie A., Blachly, James S., Rogers, Kerry A., Moran, Mollie E., Anghelina, Mirela, Jones, Jeffrey A., Grever, Michael R.
izdano v Blood Adv (2019)

Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effective

od Andritsos, Leslie A., Dunavin, Neil, Lozanski, Gerard, Jones, Jeffrey A., Blachly, James S., Lucas, David M., Byrd, John C., Kraut, Eric, Grever, Michael R.
izdano v Haematologica (2015)

Detection of toxigenic Clostridium difficile colonization in patients admitted to the hospital for chemotherapy or haematopoietic cell transplantation

od Vaughn, John L., Balada-Llasat, Joan-Miquel, Lamprecht, Misty, Huang, Ying, Anghelina, Mirela, El Boghdadly, Zeinab, Bishop-Hill, Karen, Childs, Rachel, Pancholi, Preeti, Andritsos, Leslie A.
izdano v J Med Microbiol (2018)

A single center’s experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation

od Haverkos, Bradley M., Huang, Ying, Elder, Patrick, O’Donnell, Lynn, Scholl, Diane, Whittaker, Becky, Vasu, Sumi, Penza, Sam, Andritsos, Leslie A., Devine, Steven M., Jaglowski, Samantha M.
izdano v Bone Marrow Transplant (2017)

Dic(17;18)(p11.2;p11.2) is a recurring abnormality in chronic lymphocytic leukaemia associated with aggressive disease

od Woyach, Jennifer A., Heerema, Nyla A., Zhao, John, McFaddin, Andrew, Stark, Amy, Lin, Thomas S., Andritsos, Leslie A., Blum, Kristie A., Flynn, Joseph M., Jones, Jeffrey A., Byrd, John C.
Izdano 2009

Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia

od Jaglowski, Samantha M., Ruppert, Amy S., Heerema, Nyla A., Bingman, Anissa, Flynn, Joseph M., Grever, Michael R., Jones, Jeffrey A., Elder, Patrick, Devine, Steven M., Byrd, John C., Andritsos, Leslie A.
Izdano 2012

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma

od Jaglowski, Samantha M., Ruppert, Amy S., Hofmeister, Craig C., Elder, Patrick, Blum, William, Klisovic, Rebecca, Vasu, Sumithira, Penza, Sam, Efebera, Yvonne A, Benson, Don M., Devine, Steven M., Andritsos, Leslie A
Izdano 2014

The regulation of tumor‐suppressive microRNA, miR‐126, in chronic lymphocytic leukemia

od Guinn, Daphne, Lehman, Amy, Fabian, Catherine, Yu, Lianbo, Maddocks, Kami, Andritsos, Leslie A., Jones, Jeffrey A., Flynn, Joseph M., Jaglowski, Samantha M., Woyach, Jennifer A., Byrd, John C., Johnson, Amy J.
izdano v Cancer Med (2017)

Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing

od Dubovsky, Jason A., Chappell, Danielle L., Harrington, Bonnie K., Agrawal, Kitty, Andritsos, Leslie A., Flynn, Joseph M., Jones, Jeffrey A., Paulaitis, Michael E., Bolon, Brad, Johnson, Amy J., Byrd, John C., Muthusamy, Natarajan
Izdano 2013

Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia

od Heerema, Nyla A., Muthusamy, Natarajan, Zhao, Qiuhong, Ruppert, Amy S., Breidenbach, Heather, Andritsos, Leslie A., Grever, Michael R., Maddocks, Kami J., Woyach, Jennifer, Awan, Farrukh, Long, Meixiao, Gordon, Amber, Coombes, Caitlin, Byrd, John C.
izdano v Haematologica (2020)

Early intervention with lenalidomide in patients with high-risk chronic lymphocytic leukemia

od Thangavadivel, Shanmugapriya, Zhao, Qiuhong, Epperla, Narendranath, Rike, Lindsey, Mo, Xiaokui, Badawi, Mohamed, Bystry, Darlene M., Phelps, Mitch A., Andritsos, Leslie A., Rogers, Kerry A., Jones, Jeffrey, Woyach, Jennifer A., Byrd, John C., Awan, Farrukh T.
izdano v Clin Cancer Res (2020)

Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center

od Stephens, Deborah M., Ruppert, Amy S., Jones, Jeffrey, Woyach, Jennifer, Maddocks, Kami, Jaglowski, Samantha, Andritsos, Leslie A., Flynn, Joseph M., Grever, Michael R., Lozanski, Gerard, Johnson, Amy J., Muthusamy, Natarajan, Heerema, Nyla A., Byrd, John C.
Izdano 2014

A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemia()

od Maddocks, Kami, Ruppert, Amy S., Browning, Rebekah, Jones, Jeffrey, Flynn, Joseph, Kefauver, Cheryl, Gao, Yue, Jiang, Yao, Rozewski, Darlene M., Poi, Ming, Phelps, Mitch A., Harper, Erica, Johnson, Amy J., Byrd, John C., Andritsos, Leslie A.
izdano v Leuk Res (2014)